FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4360816900> ?p ?o ?g. }

• W4360816900 endingPage "e0283576" @default.
• W4360816900 startingPage "e0283576" @default.
• W4360816900 abstract "COVID-19 oral treatments require initiation within 5 days of symptom onset. Although antigen tests are less sensitive than RT-PCR, rapid results could facilitate entry to treatment. We collected anterior nasal swabs for BinaxNOW and RT-PCR testing and clinical data at a walk-up, community site in San Francisco, California between January and June 2022. SARS-CoV-2 genomic sequences were generated from positive samples and classified according to subtype and variant. Monte Carlo simulations were conducted to estimate the expected proportion of SARS-CoV-2 infected persons who would have been diagnosed within 5 days of symptom onset using RT-PCR versus BinaxNOW testing. Among 25,309 persons tested with BinaxNOW, 2,799 had concomitant RT-PCR. 1137/2799 (40.6%) were SARS-CoV-2 RT-PCR positive. We identified waves of predominant omicron BA.1, BA.2, BA.2.12, BA.4, and BA.5 among 720 sequenced samples. Among 1,137 RT-PCR positive samples, 788/1137 (69%) were detected by BinaxNOW; 94% (669/711) of those with Ct value <30 were detected by BinaxNOW. BinaxNOW detection was consistent over lineages. In analyses to evaluate entry to treatment, BinaxNOW detected 81.7% (361/442, 95% CI: 77–85%) of persons with COVID-19 within 5 days of symptom onset. In comparison, RT-PCR (24-hour turnaround) detected 84.2% (372/442, 95% CI: 80–87%) and RT-PCR (48-hour turnaround) detected 67.0% (296/442, 95% CI: 62–71%) of persons with COVID-19 within 5 days of symptom onset. BinaxNOW detected high viral load from anterior nasal swabs consistently across omicron sublineages emerging between January and June of 2022. Simulations support BinaxNOW as an entry point for COVID-19 treatment in a community field setting." @default.
• W4360816900 created "2023-03-25" @default.
• W4360816900 creator A5007197738 @default.
• W4360816900 creator A5009068247 @default.
• W4360816900 creator A5009920970 @default.
• W4360816900 creator A5012145700 @default.
• W4360816900 creator A5015370651 @default.
• W4360816900 creator A5016931172 @default.
• W4360816900 creator A5017781466 @default.
• W4360816900 creator A5020624020 @default.
• W4360816900 creator A5020896370 @default.
• W4360816900 creator A5026626169 @default.
• W4360816900 creator A5029668724 @default.
• W4360816900 creator A5038452647 @default.
• W4360816900 creator A5039824565 @default.
• W4360816900 creator A5042022249 @default.
• W4360816900 creator A5046058269 @default.
• W4360816900 creator A5047186443 @default.
• W4360816900 creator A5047588930 @default.
• W4360816900 creator A5049249045 @default.
• W4360816900 creator A5062219656 @default.
• W4360816900 creator A5064264671 @default.
• W4360816900 creator A5068971702 @default.
• W4360816900 creator A5069551580 @default.
• W4360816900 creator A5073909894 @default.
• W4360816900 creator A5084391884 @default.
• W4360816900 date "2023-03-24" @default.
• W4360816900 modified "2023-09-25" @default.
• W4360816900 title "Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges" @default.
• W4360816900 cites W3048795936 @default.
• W4360816900 cites W3080540097 @default.
• W4360816900 cites W3092462291 @default.
• W4360816900 cites W3108601158 @default.
• W4360816900 cites W3114120261 @default.
• W4360816900 cites W3118748928 @default.
• W4360816900 cites W3121555256 @default.
• W4360816900 cites W3130935319 @default.
• W4360816900 cites W3143386891 @default.
• W4360816900 cites W4200000190 @default.
• W4360816900 cites W4200328944 @default.
• W4360816900 cites W4213199075 @default.
• W4360816900 cites W4214845310 @default.
• W4360816900 cites W4220747336 @default.
• W4360816900 cites W4220967778 @default.
• W4360816900 cites W4220987722 @default.
• W4360816900 cites W4224317130 @default.
• W4360816900 cites W4225131924 @default.
• W4360816900 cites W4226069315 @default.
• W4360816900 cites W4283392915 @default.
• W4360816900 cites W4283718348 @default.
• W4360816900 cites W4290643781 @default.
• W4360816900 cites W4304117553 @default.
• W4360816900 cites W4318479200 @default.
• W4360816900 doi "https://doi.org/10.1371/journal.pone.0283576" @default.
• W4360816900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36961855" @default.
• W4360816900 hasPublicationYear "2023" @default.
• W4360816900 type Work @default.
• W4360816900 citedByCount "0" @default.
• W4360816900 crossrefType "journal-article" @default.
• W4360816900 hasAuthorship W4360816900A5007197738 @default.
• W4360816900 hasAuthorship W4360816900A5009068247 @default.
• W4360816900 hasAuthorship W4360816900A5009920970 @default.
• W4360816900 hasAuthorship W4360816900A5012145700 @default.
• W4360816900 hasAuthorship W4360816900A5015370651 @default.
• W4360816900 hasAuthorship W4360816900A5016931172 @default.
• W4360816900 hasAuthorship W4360816900A5017781466 @default.
• W4360816900 hasAuthorship W4360816900A5020624020 @default.
• W4360816900 hasAuthorship W4360816900A5020896370 @default.
• W4360816900 hasAuthorship W4360816900A5026626169 @default.
• W4360816900 hasAuthorship W4360816900A5029668724 @default.
• W4360816900 hasAuthorship W4360816900A5038452647 @default.
• W4360816900 hasAuthorship W4360816900A5039824565 @default.
• W4360816900 hasAuthorship W4360816900A5042022249 @default.
• W4360816900 hasAuthorship W4360816900A5046058269 @default.
• W4360816900 hasAuthorship W4360816900A5047186443 @default.
• W4360816900 hasAuthorship W4360816900A5047588930 @default.
• W4360816900 hasAuthorship W4360816900A5049249045 @default.
• W4360816900 hasAuthorship W4360816900A5062219656 @default.
• W4360816900 hasAuthorship W4360816900A5064264671 @default.
• W4360816900 hasAuthorship W4360816900A5068971702 @default.
• W4360816900 hasAuthorship W4360816900A5069551580 @default.
• W4360816900 hasAuthorship W4360816900A5073909894 @default.
• W4360816900 hasAuthorship W4360816900A5084391884 @default.
• W4360816900 hasBestOaLocation W43608169001 @default.
• W4360816900 hasConcept C126322002 @default.
• W4360816900 hasConcept C2779134260 @default.
• W4360816900 hasConcept C2779384505 @default.
• W4360816900 hasConcept C3007834351 @default.
• W4360816900 hasConcept C3008058167 @default.
• W4360816900 hasConcept C524204448 @default.
• W4360816900 hasConcept C71924100 @default.
• W4360816900 hasConcept C90924648 @default.
• W4360816900 hasConceptScore W4360816900C126322002 @default.
• W4360816900 hasConceptScore W4360816900C2779134260 @default.
• W4360816900 hasConceptScore W4360816900C2779384505 @default.
• W4360816900 hasConceptScore W4360816900C3007834351 @default.
• W4360816900 hasConceptScore W4360816900C3008058167 @default.
• W4360816900 hasConceptScore W4360816900C524204448 @default.

• next